(Q43711820)

English

Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.

scientific article published in August 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

atrial fibrillation

1 reference

based on heuristic

inferred from title

author name string

A K Agarwal

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

P Venugopalan

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

437-440

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Adrenergic nervous system in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Beta-blocking agents in heart failure. Should they be used and how?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

The role of beta-blockers in left ventricular dysfunction and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Beta blockers and the failing heart: is it time for a U-turn?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Prevention of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

The evidence for beta blockers in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Cardiac autonomic denervation in congestive heart failure: comparison of Chagas' heart disease with other dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Second- and third-generation beta-blocking drugs in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

21 January 2018

Catecholamines and their blockade in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900130-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(01)00130-1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43711820&oldid=2102753540"